BMS-986209 / BMS - LARVOL DELTA

A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants (clinicaltrials.gov) - P1; N=114; Completed; Sponsor: Bristol-Myers Squibb; Not yet recruiting ➔ Completed; Trial completion date: Aug 2020 ➔ Aug 2021; Trial primary completion date: Jul 2020 ➔ Aug 2021

Clinical • Trial completion • Trial completion date • Trial primary completion date

A First-in-Human Study to Assess Single and Multiple Doses of BMS-986209 in Healthy Participants (clinicaltrials.gov) - P1; N=88; Not yet recruiting; Sponsor: Bristol-Myers Squibb

Clinical • New P1 trial